Unknown

Dataset Information

0

Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes.


ABSTRACT: Background: In contrast to adults, Trypanosoma cruzi-infected children have more broadly functional Trypanosoma cruzi-specific T cells, and the total T-cell compartment exhibits fewer signs of immune exhaustion. However, not much is known about the link between immunocompetence and the treatment efficacy for human Chagas disease. Methods: Using cytokine enzyme-linked immunosorbent spot (ELISPOT) polychromatic flow cytometry, cytometric bead assay, multiplex serological assays and quantitative PCR, we evaluated T. cruzi-specific T-cell and antibody immune responses, T-cell phenotypes and parasitemia in children in the early chronic phase of Chagas disease undergoing anti-Trypanosoma cruzi treatment. Results: Treatment with benznidazole or nifurtimox induced a decline in T. cruzi-specific IFN-?- and IL-2-producing cells and proinflammatory cytokines and chemokines. T-cell responses became detectable after therapy in children bearing T-cell responses under background levels prior to treatment. The total frequencies of effector, activated and antigen-experienced T cells also decreased following anti-T. cruzi therapy, along with an increase in T cells expressing the receptor of the homeostatic cytokine IL-7. Posttreatment changes in several of these markers distinguished children with a declining serologic response suggestive of successful treatment from those with sustained serological responses in a 5-year follow-up study. A multivariate analysis demonstrated that lower frequency of CD4+CD45RA-CCR7-CD62L- T cells prior to drug therapy was an independent indicator of successful treatment. Conclusions: These findings further validate the usefulness of alternative metrics to monitor treatment outcomes. Distinct qualitative and quantitative characteristics of T cells prior to drug therapy may be linked to treatment efficacy.

SUBMITTER: Albareda MC 

PROVIDER: S-EPMC6146084 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Distinct Treatment Outcomes of Antiparasitic Therapy in <i>Trypanosoma cruzi</i>-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes.

Albareda María C MC   Natale María A MA   De Rissio Ana M AM   Fernandez Marisa M   Serjan Alicia A   Alvarez María G MG   Cooley Gretchen G   Shen Huifeng H   Viotti Rodolfo R   Bua Jacqueline J   Castro Eiro Melisa D MD   Nuñez Myriam M   Fichera Laura E LE   Lococo Bruno B   Scollo Karenina K   Tarleton Rick L RL   Laucella Susana A SA  

Frontiers in immunology 20180913


<b>Background:</b> In contrast to adults, <i>Trypanosoma cruzi</i>-infected children have more broadly functional <i>Trypanosoma cruzi</i>-specific T cells, and the total T-cell compartment exhibits fewer signs of immune exhaustion. However, not much is known about the link between immunocompetence and the treatment efficacy for human Chagas disease. <b>Methods:</b> Using cytokine enzyme-linked immunosorbent spot (ELISPOT) polychromatic flow cytometry, cytometric bead assay, multiplex serologica  ...[more]

Similar Datasets

| S-EPMC9453042 | biostudies-literature
2008-02-06 | GSE7047 | GEO
| S-EPMC8159965 | biostudies-literature
| S-EPMC3545738 | biostudies-literature
2009-08-04 | GSE17330 | GEO
| S-EPMC2825022 | biostudies-literature
| S-EPMC2861399 | biostudies-literature
2009-09-23 | GSE18175 | GEO
| S-EPMC5064609 | biostudies-literature
| S-EPMC6524312 | biostudies-literature